Xstrahl’s radiotherapy systems can be used to treat benign skin disorders, such as keloids, which usually demonstrate a high recurrence rate. To date, there has been no single, standardized modality agreed upon to produce the best results in the treatment of these...
The consequences of low to moderate doses of ionizing radiation (IR), especially for children exposed to CT scans, remains a challenging scientific topic. So far, no proper experimental models are available to better comprehend the consequences of exposure of the...
Non-melanoma skin cancers (NMSC) are the most commonly diagnosed cancers in the world. Despite their relatively low malignant potential and mortality rate, NMSC are associated with a high morbidity and substantial treatment cost, and they significantly affect patient...
Radiotherapy (RT) enhances innate and adaptive antitumor immunity; however, the effects of radiation on suppressive immune cells, such as regulatory T cells (Treg), in the tumor microenvironment (TME) are not fully elucidated. Although previous reports suggest an...
Neuroblastoma has one of the lowest survival rates of all childhood cancers despite the use of intensive treatment regimens usually consisting of a mix of surgery, chemotherapy, radiotherapy, stem cell transplant, immunotherapy and retinoid therapy. However, because...
Radiation therapy, traditionally used to successfully treat many internal cancers, can also provide highly effective—and often superior—therapy for skin cancers. Electron radiation therapy, which uses high-energy rays, is the choice for safe, effective skin cancer...
A novel RADiant system provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer and superficial keloid lesions. The Xstrahl (Camberley, United Kingdom) RADiant System is a mobile, compact, ergonomic superficial X-ray therapy...
At the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) researchers announced the development of an efficient and reproducible method to deliver craniospinal irradiation to patient-derived xenograft in mouse models. Despite aggressive...
November 9th, 2017 – Following the supply of an Xstrahl 200 to the Island of Cuba, Xstrahl Medical has reached out to the rest of South America and Spanish speaking countries to solve the ever-present problem of skin cancer. Whilst pale skin is at a higher risk of...
Contact Us